*Result*: Albi grade enables risk stratification for bleeding events and refines prognostic prediction in advanced HCC following atezolizumab and bevacizumab
*Author/editor-in-chief*:
*Publication*:
Freiburg : Universität, 2025
*Physical description scale*:
1 Online-Ressource
*Format*:
*Language*:
*eng*
*Notes*:
Journal of hepatocellular carcinoma. - Volume 12 (2025) , 671-683, ISSN: 2253-5969
*DOI*:
10.2147/jhc.s462701